Mind Medicine (MindMed) (MNMD) Competitors $11.97 -0.25 (-2.05%) Closing price 04:00 PM EasternExtended Trading$11.91 -0.06 (-0.50%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock MNMD vs. AAPG, AKRO, LNTH, NAMS, MIRM, ACAD, VKTX, TLX, ADMA, and AMRXShould you be buying Mind Medicine (MindMed) stock or one of its competitors? The main competitors of Mind Medicine (MindMed) include Ascentage Pharma Group International (AAPG), Akero Therapeutics (AKRO), Lantheus (LNTH), NewAmsterdam Pharma (NAMS), Mirum Pharmaceuticals (MIRM), ACADIA Pharmaceuticals (ACAD), Viking Therapeutics (VKTX), Telix Pharmaceuticals (TLX), ADMA Biologics (ADMA), and Amneal Pharmaceuticals (AMRX). These companies are all part of the "pharmaceutical products" industry. Mind Medicine (MindMed) vs. Its Competitors Ascentage Pharma Group International Akero Therapeutics Lantheus NewAmsterdam Pharma Mirum Pharmaceuticals ACADIA Pharmaceuticals Viking Therapeutics Telix Pharmaceuticals ADMA Biologics Amneal Pharmaceuticals Ascentage Pharma Group International (NASDAQ:AAPG) and Mind Medicine (MindMed) (NASDAQ:MNMD) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability. Do institutionals & insiders have more ownership in AAPG or MNMD? 27.9% of Mind Medicine (MindMed) shares are held by institutional investors. 2.3% of Mind Medicine (MindMed) shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has higher valuation and earnings, AAPG or MNMD? Ascentage Pharma Group International has higher revenue and earnings than Mind Medicine (MindMed). CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAscentage Pharma Group International$134.35M26.96-$55.54MN/AN/AMind Medicine (MindMed)N/AN/A-$108.68M-$1.53-7.82 Do analysts recommend AAPG or MNMD? Mind Medicine (MindMed) has a consensus target price of $26.50, suggesting a potential upside of 121.39%. Given Mind Medicine (MindMed)'s higher possible upside, analysts plainly believe Mind Medicine (MindMed) is more favorable than Ascentage Pharma Group International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ascentage Pharma Group International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Mind Medicine (MindMed) 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00 Is AAPG or MNMD more profitable? Ascentage Pharma Group International's return on equity of 0.00% beat Mind Medicine (MindMed)'s return on equity.Company Net Margins Return on Equity Return on Assets Ascentage Pharma Group InternationalN/A N/A N/A Mind Medicine (MindMed) N/A -50.24%-39.41% Does the media favor AAPG or MNMD? In the previous week, Ascentage Pharma Group International had 1 more articles in the media than Mind Medicine (MindMed). MarketBeat recorded 2 mentions for Ascentage Pharma Group International and 1 mentions for Mind Medicine (MindMed). Mind Medicine (MindMed)'s average media sentiment score of 0.65 beat Ascentage Pharma Group International's score of 0.25 indicating that Mind Medicine (MindMed) is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ascentage Pharma Group International 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mind Medicine (MindMed) 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMind Medicine (MindMed) beats Ascentage Pharma Group International on 6 of the 11 factors compared between the two stocks. Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MNMD vs. The Competition Export to ExcelMetricMind Medicine (MindMed)MED IndustryMedical SectorNASDAQ ExchangeMarket Cap$929.79M$3.35B$6.12B$10.65BDividend YieldN/A2.29%5.69%4.73%P/E Ratio-7.8221.4185.6126.85Price / SalesN/A466.25612.81135.18Price / CashN/A47.6737.7861.77Price / Book3.7310.0613.256.70Net Income-$108.68M-$52.22M$3.30B$276.44M7 Day Performance1.53%5.84%4.70%3.13%1 Month Performance29.83%12.05%8.43%10.21%1 Year Performance128.00%26.13%88.01%40.35% Mind Medicine (MindMed) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MNMDMind Medicine (MindMed)2.4693 of 5 stars$11.97-2.0%$26.50+121.4%+119.4%$929.79MN/A-7.8240AAPGAscentage Pharma Group InternationalN/A$39.86+1.2%N/AN/A$3.71B$134.35M0.00600News CoverageAKROAkero Therapeutics3.6968 of 5 stars$46.04-0.1%$81.14+76.2%+63.0%$3.68BN/A-23.0230Positive NewsLNTHLantheus4.6647 of 5 stars$52.70-2.1%$85.50+62.2%-51.1%$3.66B$1.52B14.02700Trending NewsNAMSNewAmsterdam Pharma2.9701 of 5 stars$32.48+5.9%$42.00+29.3%+78.3%$3.66B$64.01M-20.054High Trading VolumeMIRMMirum Pharmaceuticals3.4467 of 5 stars$72.53-0.6%$76.50+5.5%+84.7%$3.64B$336.89M-59.94140Positive NewsACADACADIA Pharmaceuticals4.4762 of 5 stars$21.59-1.0%$29.12+34.9%+43.0%$3.64B$957.80M16.23510VKTXViking Therapeutics4.0228 of 5 stars$32.28+8.6%$86.42+167.7%-50.3%$3.63BN/A-21.1020TLXTelix Pharmaceuticals4.3251 of 5 stars$10.18-1.0%$21.00+106.3%N/A$3.45B$516.72M0.00N/AShort Interest ↓Gap DownADMAADMA Biologics3.7464 of 5 stars$14.07-4.0%$27.67+96.6%-30.7%$3.36B$474.17M16.36530Positive NewsAMRXAmneal Pharmaceuticals2.8781 of 5 stars$10.55+1.5%$12.00+13.7%+22.0%$3.31B$2.79B1,056.068,100 Related Companies and Tools Related Companies AAPG Alternatives AKRO Alternatives LNTH Alternatives NAMS Alternatives MIRM Alternatives ACAD Alternatives VKTX Alternatives TLX Alternatives ADMA Alternatives AMRX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MNMD) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
